We are live on ! Find out more
MLL

Moody Lynn & Lieberson Portfolio holdings

AUM $1.9B
1-Year Est. Return 27.82%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$628M
AUM Growth
+$1.43M
Cap. Flow
+$13.5M
Cap. Flow %
2.14%
Top 10 Hldgs %
27.41%
Holding
214
New
33
Increased
73
Reduced
69
Closed
24

Top Sells

Rank Stock Value
1
EWG icon
iShares MSCI Germany ETF
EWG
+$20.4M
2
AMGN icon
Amgen
AMGN
+$18.9M
3
BIIB icon
Biogen
BIIB
+$14.4M
4
UNP icon
Union Pacific
UNP
+$8.7M
5
BA icon
Boeing
BA
+$7.89M

Sector Composition

Rank Sector Weight
1 Healthcare 21.32%
2 Financials 20.81%
3 Communication Services 10.39%
4 Consumer Discretionary 9.6%
5 Technology 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWU icon
26
iShares MSCI United Kingdom ETF
EWU
$4.14B
$7.72M 1.23%
+211,514
New +$8.09M
C icon
27
Citigroup
C
$222B
$7.7M 1.23%
+139,363
New +$7.58M
GILD icon
28
Gilead Sciences
GILD
$162B
$7.15M 1.14%
61,080
+2,916
+5% +$319K
GS icon
29
Goldman Sachs
GS
$300B
$7.08M 1.13%
33,891
+31,927
+1,626% +$6.51M
MET icon
30
MetLife
MET
$61.9B
$7.01M 1.12%
140,502
+135,935
+2,976% +$6.44M
GE icon
31
GE Aerospace
GE
$374B
$6.93M 1.1%
54,438
+37,118
+214% +$4.81M
TRV icon
32
Travelers Companies
TRV
$78.1B
$6.91M 1.1%
71,505
-16,943
-19% -$1.73M
BLK icon
33
Blackrock
BLK
$169B
$6.87M 1.09%
19,858
-5,424
-21% -$1.98M
CVS icon
34
CVS Health
CVS
$133B
$6.84M 1.09%
65,260
+3,892
+6% +$398K
SPY icon
35
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$6.69M 1.06%
32,488
+240
+0.7% +$50.5K
KEY icon
36
KeyCorp
KEY
$24.2B
$6.59M 1.05%
438,495
+417,774
+2,016% +$6.16M
PSX icon
37
Phillips 66
PSX
$84.9B
$6.28M 1%
77,895
-1,847
-2% -$147K
EWJ icon
38
iShares MSCI Japan ETF
EWJ
$21.9B
$6.19M 0.99%
120,888
+3,886
+3% +$202K
JNJ icon
39
Johnson & Johnson
JNJ
$618B
$6.18M 0.98%
63,372
-2,539
-4% -$254K
HBAN icon
40
Huntington Bancshares
HBAN
$34.4B
$6.09M 0.97%
538,499
-8,129
-1% -$91K
BIIB icon
41
Biogen
BIIB
$30B
$6.08M 0.97%
15,059
-35,816
-70% -$14.4M
EA icon
42
Electronic Arts
EA
$53B
$6M 0.95%
90,200
+9,560
+12% +$588K
RF icon
43
Regions Financial
RF
$26.4B
$5.8M 0.92%
+559,535
New +$5.64M
TEVA icon
44
Teva Pharmaceuticals
TEVA
$40.8B
$5.65M 0.9%
95,538
-2,216
-2% -$137K
REGN icon
45
Regeneron Pharmaceuticals
REGN
$78.5B
$5.59M 0.89%
+10,956
New +$5.35M
EPI icon
46
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$5.27M 0.84%
243,241
-84,416
-26% -$1.86M
INTU icon
47
Intuit
INTU
$86.5B
$5.19M 0.83%
51,529
-32,578
-39% -$3.32M
WWAV
48
DELISTED
The WhiteWave Foods Company
WWAV
$5.02M 0.8%
102,685
-1,087
-1% -$50.9K
SYNA icon
49
Synaptics
SYNA
$4.19B
$5.01M 0.8%
+57,769
New +$5.27M
EOG icon
50
EOG Resources
EOG
$79.2B
$4.62M 0.73%
52,712
+13,733
+35% +$1.27M

Similar funds

Moody Lynn & Lieberson's Q2 2015 Portfolio in Review

As of Q2 2015, Moody Lynn & Lieberson held 214 positions worth $628M, up 0.23% from $627M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Moody Lynn & Lieberson's Q2 2015 filing shows 33 new, 73 increased, 69 reduced and 24 closed positions. Its largest new stake was Netflix: 2,215,780 shares worth $2.97M. The largest sale was iShares MSCI Germany ETF, an estimated $20.4M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Financials and Communication Services.

  • Moody Lynn & Lieberson's largest Q2 2015 buy was Netflix: 2,215,780 shares worth $2.97M.
  • Moody Lynn & Lieberson added most to Newell Brands in Q2 2015, an estimated $10.6M increase.
  • Moody Lynn & Lieberson's biggest Q2 2015 reduction was Biogen, cutting an estimated $14.4M.
  • Moody Lynn & Lieberson fully exited iShares MSCI Germany ETF in Q2 2015, selling an estimated $20.4M.
  • Moody Lynn & Lieberson's ten largest holdings make up 27% of its $628M portfolio in Q2 2015.
  • Moody Lynn & Lieberson opened 33 new positions and closed 24 in Q2 2015.
  • Moody Lynn & Lieberson's portfolio value rose 0.23% quarter-over-quarter to $628M.

Based on Moody Lynn & Lieberson's 13F filing for Q2 2015, filed 25 Aug 2015.